Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal–Epithelial Transition in Head and Neck Cancer Cells

The epithelial–mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal–epithelial transition (MET), the reverse process of EMT, is a crucial s...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 73; no. 13; pp. 4147 - 4157
Main Authors Chang, Cheng-Chi, Hsu, Wen-Hao, Wang, Chen-Chien, Chou, Chun-Hung, Kuo, Mark Yen-Ping, Lin, Been-Ren, Chen, Szu-Ta, Tai, Shyh-Kuan, Kuo, Min-Liang, Yang, Muh-Hwa
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 01.07.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The epithelial–mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal–epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC. Cancer Res; 73(13); 4147–57. ©2013 AACR.
AbstractList The epithelial-mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal-epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC.The epithelial-mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal-epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC.
The epithelial–mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal–epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC. Cancer Res; 73(13); 4147–57. ©2013 AACR.
The epithelial-mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal-epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC.
Author Kuo, Min-Liang
Chou, Chun-Hung
Kuo, Mark Yen-Ping
Tai, Shyh-Kuan
Wang, Chen-Chien
Lin, Been-Ren
Chang, Cheng-Chi
Hsu, Wen-Hao
Chen, Szu-Ta
Yang, Muh-Hwa
Author_xml – sequence: 1
  givenname: Cheng-Chi
  surname: Chang
  fullname: Chang, Cheng-Chi
– sequence: 2
  givenname: Wen-Hao
  surname: Hsu
  fullname: Hsu, Wen-Hao
– sequence: 3
  givenname: Chen-Chien
  surname: Wang
  fullname: Wang, Chen-Chien
– sequence: 4
  givenname: Chun-Hung
  surname: Chou
  fullname: Chou, Chun-Hung
– sequence: 5
  givenname: Mark Yen-Ping
  surname: Kuo
  fullname: Kuo, Mark Yen-Ping
– sequence: 6
  givenname: Been-Ren
  surname: Lin
  fullname: Lin, Been-Ren
– sequence: 7
  givenname: Szu-Ta
  surname: Chen
  fullname: Chen, Szu-Ta
– sequence: 8
  givenname: Shyh-Kuan
  surname: Tai
  fullname: Tai, Shyh-Kuan
– sequence: 9
  givenname: Min-Liang
  surname: Kuo
  fullname: Kuo, Min-Liang
– sequence: 10
  givenname: Muh-Hwa
  surname: Yang
  fullname: Yang, Muh-Hwa
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27502034$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23687336$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFu1DAQhi1URLeFRwD5gsQlxY7tOCtOq6jdIrWFw3K2Zp2J1pB1Ftsp2hviFXhDngSn3VKJQ0-Wx99vj-c7IUd-8EjIa87OOFf1e8ZYXSipy7NmcVPwspCsVs_IjCtRF1pKdURm_5hjchLj17xVnKkX5LgUVa2FqGbkVzN4jza5W6QrF-OIdBmGH2lDL8CmIdDFdAYJI_3cj8HthoTe7ukSfS6Bb-k1xlzZ7LfQ__n5-3zn0gZ7Bz1dBfDRJTd46jy9RGjv-Bu032gD3mKgDfZ9fEmed9BHfHVYT8mXi_NVc1lcfVp-bBZXhZVMpQKwA91qxWS51hK4qizobm67ugbWzkF2pbSacSxBW0CmATqrO0AU1op1JU7Ju_t7d2H4PmJMZuuizR2Ax2GMhsuy1lpUc5HRNwd0XG-xNbvgthD25mFuGXh7ACBa6Lv8VeviI5fbLJmQmftwz9kwxBiwM9YlmGaSArjecGYmm2YyZSZTJts0vDSTzZxW_6UfHng69xdCUqXm
CODEN CNREA8
CitedBy_id crossref_primary_10_1093_carcin_bgv039
crossref_primary_10_18632_oncotarget_5328
crossref_primary_10_1002_ijc_28972
crossref_primary_10_1016_j_cell_2016_06_028
crossref_primary_10_3892_ijo_2016_3582
crossref_primary_10_1186_s13059_025_03519_4
crossref_primary_10_1002_ijc_28690
crossref_primary_10_1158_1078_0432_CCR_22_0761
crossref_primary_10_1016_j_ebiom_2020_102717
crossref_primary_10_3390_cancers12051088
crossref_primary_10_1016_j_neo_2015_01_004
crossref_primary_10_1016_j_oraloncology_2015_04_004
crossref_primary_10_1038_ncb3611
crossref_primary_10_1158_0008_5472_CAN_17_1172
crossref_primary_10_18632_oncotarget_1998
crossref_primary_10_1055_s_0038_1673588
crossref_primary_10_1177_0022034515601960
crossref_primary_10_3389_fonc_2018_00505
crossref_primary_10_3390_ijms23147689
crossref_primary_10_1186_1756_8722_7_19
crossref_primary_10_1186_s13005_016_0106_0
crossref_primary_10_1002_1878_0261_12096
crossref_primary_10_3390_biomedicines10081946
crossref_primary_10_1016_j_phymed_2018_04_016
crossref_primary_10_3390_ijms22083888
crossref_primary_10_1186_s12943_019_0983_5
crossref_primary_10_1016_j_jfma_2017_04_003
crossref_primary_10_1007_s12094_017_1751_x
crossref_primary_10_18632_oncotarget_4000
crossref_primary_10_1038_bjc_2014_153
crossref_primary_10_1146_annurev_pathol_020117_044127
crossref_primary_10_1186_s13046_023_02671_8
crossref_primary_10_3389_fonc_2018_00431
crossref_primary_10_1038_cddis_2017_248
crossref_primary_10_1101_sqb_2016_81_030957
crossref_primary_10_1186_s41232_017_0041_x
crossref_primary_10_15407_fz61_01_010
crossref_primary_10_18632_oncotarget_9549
crossref_primary_10_1016_j_jtbi_2021_110677
crossref_primary_10_1111_cas_13202
crossref_primary_10_1016_j_yexcr_2013_12_024
crossref_primary_10_18632_oncotarget_9342
crossref_primary_10_18632_oncotarget_2073
crossref_primary_10_1186_s12964_024_01957_4
crossref_primary_10_1002_cbin_10398
crossref_primary_10_1016_j_job_2024_02_005
crossref_primary_10_4014_jmb_2110_10032
crossref_primary_10_3390_cells8091017
crossref_primary_10_3390_ijms19113620
crossref_primary_10_1007_s13577_014_0092_0
crossref_primary_10_1071_RD16033
crossref_primary_10_1089_cbr_2020_3988
crossref_primary_10_1186_s12967_023_04343_9
crossref_primary_10_1016_j_molonc_2015_05_006
crossref_primary_10_1016_j_pharmthera_2016_09_002
crossref_primary_10_15430_JCP_2018_23_1_1
crossref_primary_10_3390_ijms20040891
crossref_primary_10_3892_ol_2015_3487
crossref_primary_10_1126_science_1234850
crossref_primary_10_1097_CM9_0000000000000683
crossref_primary_10_1007_s10555_021_10003_5
crossref_primary_10_1186_1475_2867_14_61
crossref_primary_10_18632_oncotarget_13957
crossref_primary_10_1007_s00432_015_2020_4
crossref_primary_10_1002_stem_2447
crossref_primary_10_3390_ijms22126626
crossref_primary_10_1016_j_trsl_2014_05_007
crossref_primary_10_1093_carcin_bgv034
crossref_primary_10_1084_jem_20140692
Cites_doi 10.1126/science.1151526
10.1371/journal.pone.0021911
10.1371/journal.pone.0041335
10.1371/journal.pone.0002888
10.1038/ncb1998
10.1242/jcs.03460
10.1016/j.cellsig.2009.12.008
10.1016/j.cell.2006.07.024
10.1016/j.stem.2010.04.014
10.1016/j.stem.2010.04.015
10.4081/gh.2010.203
10.1023/A:1008845219266
10.1053/j.gastro.2004.10.007
10.1038/nrc3184
10.1172/JCI59218
10.1158/0008-5472.CAN-10-2638
10.1016/j.cell.2009.11.007
10.1179/016164102101200573
10.1038/nm.2401
10.1016/j.bbrc.2011.07.025
10.1242/dev.024398
10.1007/s11373-008-9264-9
10.1038/embor.2011.88
10.1172/JCI39104
10.1093/jnci/djh059
10.1073/pnas.0610117104
10.1001/archotol.132.7.762
10.1038/onc.2011.423
10.1371/journal.pone.0012445
10.1038/nature06534
10.1038/ncb2099
10.1200/JCO.2008.17.0266
10.1007/s00109-007-0287-x
10.1038/cr.2010.127
10.1016/j.oraloncology.2006.07.007
10.1016/j.cell.2008.03.027
10.1016/0278-2391(90)90436-6
ContentType Journal Article
Copyright 2014 INIST-CNRS
2013 AACR.
Copyright_xml – notice: 2014 INIST-CNRS
– notice: 2013 AACR.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1158/0008-5472.CAN-12-4085
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7445
EndPage 4157
ExternalDocumentID 23687336
27502034
10_1158_0008_5472_CAN_12_4085
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-ET
18M
29B
2WC
34G
39C
53G
5GY
5RE
5VS
6J9
AAFWJ
AAJMC
AAYXX
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AETEA
AFHIN
AFOSN
AFRAH
AFUMD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
EBS
EJD
F5P
FRP
GX1
H13
IH2
KQ8
L7B
LSO
OK1
P0W
P2P
PQQKQ
RCR
RHI
RNS
SJN
TR2
UDS
W2D
W8F
WH7
WOQ
YKV
YZZ
.55
.GJ
3O-
8WZ
A6W
AFFNX
AI.
C1A
D0S
IQODW
J5H
MVM
OHT
VH1
WHG
X7M
XJT
ZCG
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c405t-aefa7d75042b74a156ca7f9cf88a0d9a4f24c701e2a7cae07aafc7faee3cc3b63
ISSN 0008-5472
1538-7445
IngestDate Thu Jul 10 23:17:38 EDT 2025
Mon Jul 21 06:04:59 EDT 2025
Mon Jul 21 09:16:07 EDT 2025
Tue Jul 01 04:18:02 EDT 2025
Thu Apr 24 23:02:57 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 13
Keywords Gene
ENT disease
Head and neck cancer
Connective tissue growth factor
Genetics
Malignant tumor
Epithelial mesenchymal transition
Cell transformation
Cell
In vitro
Pluripotency
Cancer
Language English
License CC BY 4.0
2013 AACR.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c405t-aefa7d75042b74a156ca7f9cf88a0d9a4f24c701e2a7cae07aafc7faee3cc3b63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23687336
PQID 1428773693
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_1428773693
pubmed_primary_23687336
pascalfrancis_primary_27502034
crossref_citationtrail_10_1158_0008_5472_CAN_12_4085
crossref_primary_10_1158_0008_5472_CAN_12_4085
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-07-01
PublicationDateYYYYMMDD 2013-07-01
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
– name: United States
PublicationTitle Cancer research (Chicago, Ill.)
PublicationTitleAlternate Cancer Res
PublicationYear 2013
Publisher American Association for Cancer Research
Publisher_xml – name: American Association for Cancer Research
References Mani (2022061704045961300_bib3) 2008; 133
Wellner (2022061704045961300_bib6) 2009; 11
Yu (2022061704045961300_bib9) 2007; 318
Thiery (2022061704045961300_bib2) 2009; 139
Yang (2022061704045961300_bib7) 2010; 12
Nakerakanti (2022061704045961300_bib33) 2011; 6
Li (2022061704045961300_bib11) 2010; 7
Samavarchi-Tehrani (2022061704045961300_bib12) 2010; 7
Chambers (2022061704045961300_bib29) 2009; 136
Chen (2022061704045961300_bib18) 2007; 120
Kalluri (2022061704045961300_bib1) 2009; 119
Ocaña (2022061704045961300_bib14) 2010; 20
Kok (2022061704045961300_bib24) 2007; 43
Morel (2022061704045961300_bib4) 2008; 3
Yang (2022061704045961300_bib22) 2012; 31
Glinsky (2022061704045961300_bib28) 2008; 26
Hu (2022061704045961300_bib40) 2011; 411
Lin (2022061704045961300_bib20) 2005; 128
Wong (2022061704045961300_bib23) 1990; 48
Chiou (2022061704045961300_bib38) 2010; 70
Chiang (2022061704045961300_bib32) 2010; 4
Nguyen (2022061704045961300_bib5) 2012; 12
Prince (2022061704045961300_bib27) 2007; 104
Greene (2022061704045961300_bib34) 2002
Pan (2022061704045961300_bib17) 2002; 24
2022061704045961300_bib25
Han (2022061704045961300_bib39) 2012; 7
2022061704045961300_bib26
Luft (2022061704045961300_bib15) 2008; 86
Chang (2022061704045961300_bib19) 2004; 96
Kong (2022061704045961300_bib37) 2010; 5
Garavello (2022061704045961300_bib21) 2006; 132
Celià-Terrassa (2022061704045961300_bib35) 2012; 122
Korpal (2022061704045961300_bib36) 2011; 17
Redmer (2022061704045961300_bib13) 2011; 12
Chu (2022061704045961300_bib16) 2008; 15
Takahashi (2022061704045961300_bib8) 2006; 126
Park (2022061704045961300_bib10) 2008; 451
Mork (2022061704045961300_bib31) 1998; 9
Shaulian (2022061704045961300_bib30) 2010; 22
28572507 - Cancer Res. 2017 Jun 1;77(11):3127
References_xml – volume: 318
  start-page: 1917
  year: 2007
  ident: 2022061704045961300_bib9
  article-title: Induced pluripotent stem cell lines derived from human somatic cells
  publication-title: Science
  doi: 10.1126/science.1151526
– volume: 6
  start-page: e21911
  year: 2011
  ident: 2022061704045961300_bib33
  article-title: CCN2 is required for the TGF-β induced activation of Smad1-Erk1/2 signaling network
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0021911
– volume: 7
  start-page: e41335
  year: 2012
  ident: 2022061704045961300_bib39
  article-title: Silencing SOX2 induced mesenchymal–epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0041335
– volume: 3
  start-page: e2888
  year: 2008
  ident: 2022061704045961300_bib4
  article-title: Generation of breast cancer stem cells through epithelial–mesenchymal transition
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0002888
– volume: 11
  start-page: 1487
  year: 2009
  ident: 2022061704045961300_bib6
  article-title: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1998
– volume: 120
  start-page: 2053
  year: 2007
  ident: 2022061704045961300_bib18
  article-title: CTGF enhances the motility of breast cancer cells via an integrin-αvβ3–ERK1/2-dependent S100A4-upregulated pathway
  publication-title: J Cell Sci
  doi: 10.1242/jcs.03460
– volume: 22
  start-page: 894
  year: 2010
  ident: 2022061704045961300_bib30
  article-title: AP-1-the jun proteins: oncogenes or tumor suppressors in disguise?
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2009.12.008
– volume: 126
  start-page: 663
  year: 2006
  ident: 2022061704045961300_bib8
  article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
  publication-title: Cell
  doi: 10.1016/j.cell.2006.07.024
– volume: 7
  start-page: 51
  year: 2010
  ident: 2022061704045961300_bib11
  article-title: A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2010.04.014
– volume: 7
  start-page: 64
  year: 2010
  ident: 2022061704045961300_bib12
  article-title: Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2010.04.015
– volume: 4
  start-page: 230
  year: 2010
  ident: 2022061704045961300_bib32
  article-title: Elucidating the underlying causes of oral cancer through spatial clustering in high-risk areas of Taiwan with a distinct gender ratio of incidence
  publication-title: Geospat Health
  doi: 10.4081/gh.2010.203
– volume: 9
  start-page: 37
  year: 1998
  ident: 2022061704045961300_bib31
  article-title: Squamous cell carcinomas of the head and neck in Norway, 1953–92: an epidemiologic study of a low-risk population
  publication-title: Cancer Causes Control
  doi: 10.1023/A:1008845219266
– volume: 128
  start-page: 9
  year: 2005
  ident: 2022061704045961300_bib20
  article-title: Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2004.10.007
– ident: 2022061704045961300_bib26
– volume: 12
  start-page: 133
  year: 2012
  ident: 2022061704045961300_bib5
  article-title: Cancer stem cells: an evolving concept
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3184
– volume: 122
  start-page: 1849
  year: 2012
  ident: 2022061704045961300_bib35
  article-title: Epithelial–mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI59218
– volume: 70
  start-page: 10433
  year: 2010
  ident: 2022061704045961300_bib38
  article-title: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial–mesenchymal transdifferentiation
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-2638
– start-page: 17
  year: 2002
  ident: 2022061704045961300_bib34
  article-title: Head and neck
– volume: 139
  start-page: 871
  year: 2009
  ident: 2022061704045961300_bib2
  article-title: Epithelial–mesenchymal transitions in development and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
– volume: 24
  start-page: 677
  year: 2002
  ident: 2022061704045961300_bib17
  article-title: Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma
  publication-title: Neurol Res
  doi: 10.1179/016164102101200573
– volume: 17
  start-page: 1101
  year: 2011
  ident: 2022061704045961300_bib36
  article-title: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
  publication-title: Nat Med
  doi: 10.1038/nm.2401
– volume: 411
  start-page: 786
  year: 2011
  ident: 2022061704045961300_bib40
  article-title: Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2011.07.025
– volume: 136
  start-page: 2311
  year: 2009
  ident: 2022061704045961300_bib29
  article-title: The transcriptional foundation of pluripotency
  publication-title: Development
  doi: 10.1242/dev.024398
– volume: 15
  start-page: 675
  year: 2008
  ident: 2022061704045961300_bib16
  article-title: Connective tissue growth factor (CTGF) and cancer progression
  publication-title: J Biomed Sci
  doi: 10.1007/s11373-008-9264-9
– volume: 12
  start-page: 720
  year: 2011
  ident: 2022061704045961300_bib13
  article-title: E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming
  publication-title: EMBO Rep
  doi: 10.1038/embor.2011.88
– volume: 119
  start-page: 1420
  year: 2009
  ident: 2022061704045961300_bib1
  article-title: The basics of epithelial–mesenchymal transition
  publication-title: J Clin Invest
  doi: 10.1172/JCI39104
– volume: 96
  start-page: 364
  year: 2004
  ident: 2022061704045961300_bib19
  article-title: Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djh059
– volume: 104
  start-page: 973
  year: 2007
  ident: 2022061704045961300_bib27
  article-title: Identification of a subpopulation of cells with cancer stem cell. Properties in head and neck squamous cell carcinoma
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0610117104
– volume: 132
  start-page: 762
  year: 2006
  ident: 2022061704045961300_bib21
  article-title: Risk factors for distant metastases in head and neck squamous cell carcinoma
  publication-title: Arch Otolaryngol Head Neck Surg
  doi: 10.1001/archotol.132.7.762
– volume: 31
  start-page: 2401
  year: 2012
  ident: 2022061704045961300_bib22
  article-title: Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling
  publication-title: Oncogene
  doi: 10.1038/onc.2011.423
– volume: 5
  start-page: e12445
  year: 2010
  ident: 2022061704045961300_bib37
  article-title: Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0012445
– volume: 451
  start-page: 141
  year: 2008
  ident: 2022061704045961300_bib10
  article-title: Reprogramming of human somatic cells to pluripotency with defined factors
  publication-title: Nature
  doi: 10.1038/nature06534
– volume: 12
  start-page: 982
  year: 2010
  ident: 2022061704045961300_bib7
  article-title: Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb2099
– volume: 26
  start-page: 2846
  year: 2008
  ident: 2022061704045961300_bib28
  article-title: Stemness” genomics law governs clinical behavior of human cancer: implications for decision making in disease management
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.17.0266
– volume: 86
  start-page: 1
  year: 2008
  ident: 2022061704045961300_bib15
  article-title: CCN2, the connective tissue growth factor
  publication-title: J Mol Med
  doi: 10.1007/s00109-007-0287-x
– ident: 2022061704045961300_bib25
– volume: 20
  start-page: 1086
  year: 2010
  ident: 2022061704045961300_bib14
  article-title: Epithelial plasticity, stemness and pluripotency
  publication-title: Cell Res
  doi: 10.1038/cr.2010.127
– volume: 43
  start-page: 639
  year: 2007
  ident: 2022061704045961300_bib24
  article-title: Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2006.07.007
– volume: 133
  start-page: 704
  year: 2008
  ident: 2022061704045961300_bib3
  article-title: The epithelial–mesenchymal transition generates cells with properties of stem cells
  publication-title: Cell
  doi: 10.1016/j.cell.2008.03.027
– volume: 48
  start-page: 385
  year: 1990
  ident: 2022061704045961300_bib23
  article-title: Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas—OC1 and OC2
  publication-title: J Oral Maxillofac Surg
  doi: 10.1016/0278-2391(90)90436-6
– reference: 28572507 - Cancer Res. 2017 Jun 1;77(11):3127
SSID ssj0005105
Score 2.3907633
Snippet The epithelial–mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to...
The epithelial-mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 4147
SubjectTerms Animals
Antineoplastic agents
Binding Sites
Biological and medical sciences
Carcinoma, Squamous Cell - metabolism
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Cell Movement
Connective Tissue Growth Factor - physiology
Disease-Free Survival
Epithelial-Mesenchymal Transition
Gene Expression Regulation, Neoplastic
Head and Neck Neoplasms - metabolism
Head and Neck Neoplasms - mortality
Head and Neck Neoplasms - pathology
HEK293 Cells
Homeodomain Proteins - genetics
Homeodomain Proteins - metabolism
Humans
Kaplan-Meier Estimate
Medical sciences
Mice
Mice, Nude
Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
Nanog Homeobox Protein
Neoplasm Invasiveness
Neoplasm Transplantation
Neoplastic Stem Cells - metabolism
Octamer Transcription Factor-3 - genetics
Octamer Transcription Factor-3 - metabolism
Oligonucleotide Array Sequence Analysis
Otorhinolaryngology (head neck, general aspects and miscellaneous)
Otorhinolaryngology. Stomatology
Pharmacology. Drug treatments
Proto-Oncogene Proteins c-jun - metabolism
SOXB1 Transcription Factors - genetics
SOXB1 Transcription Factors - metabolism
Spheroids, Cellular - metabolism
Transcriptional Activation
Transcriptome
Tumors
Title Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal–Epithelial Transition in Head and Neck Cancer Cells
URI https://www.ncbi.nlm.nih.gov/pubmed/23687336
https://www.proquest.com/docview/1428773693
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ditQwFA7jCiKI-O_4s0TwbujYadOmvRzKLoOyg8Iu7F1J09RZtnaGnRbRK_EVfDcfwCfxnKRpuzL-rDdlyCRpyflykpx85xxCXqqCZyr0cif2hOvgCcGJPBU7MoOplwtexLkmyC7DxQl7fRqcjkbfB6ylps6m8vNOv5L_kSqUgVzRS_YKku06hQL4DfKFJ0gYnv8kY81S0QoLxhwHEE1JH-vV5FBn0ZnMpU5epraTt2UD2mFda0dLDDVtQjMfoe-RXH36IErLevAPNuimUaIlXS9kZ5YOuQA46FZLJc8nCcLlYpKostwOd7hteRtEaKVviQ3dQ6ujspwOjA-JNVcnK1W9d6BiB7Nto-l_qnIWYt2b_fvqWLv3Y0tW68b800CLpl2PW3MGppbg1pxhVXTkBMzk85mqXitzZuJOWrVtMqBYePoDJcxmJohnu6ADAPnuxSKIDLvSvHCazJdIVMGYb_3qaBkBvyyaHZVRH6KCCC_xoxS7SaGbdOal2M01ct2D4wtm1njzro9iH7TUWvvm1rMMunm182su7ZlubcQWpm9h8q78_mCkN0jHd8jt9mRD5wamd8lIVffIjaOWu3GffO3RSg1aqUErNWilHVrpEK1Uo5UC7ugArT--fOtxSnuc0rOKIk51fcQpNXikGqcPyMnhwXGycNoMII6Eg0TtCFUInmMGAi_jTIAmkag-ZBFFws1jwQqPSe7OlCe4FMrlQhSSF0IpX0o_C_2HZK9aV-oxoUE0c7M8zkAaikmZZ4GbB9LLYx_gwXg4JsyOcSrb8PiYpaVM_yjhMZl2zTYmPszfGuxfEmDXChMteK7PxuSFlWgKqh7v70Sl1s02xeCInPth7I_JIyPqvrUfRhjZ9MlVv-cpudlPw2dkr75o1HPYZ9fZvgbtTzdMzIk
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Connective+Tissue+Growth+Factor+Activates+Pluripotency+Genes+and+Mesenchymal%E2%80%93Epithelial+Transition+in+Head+and+Neck+Cancer+Cells&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Chang%2C+Cheng-Chi&rft.au=Hsu%2C+Wen-Hao&rft.au=Wang%2C+Chen-Chien&rft.au=Chou%2C+Chun-Hung&rft.date=2013-07-01&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=73&rft.issue=13&rft.spage=4147&rft.epage=4157&rft_id=info:doi/10.1158%2F0008-5472.CAN-12-4085&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_0008_5472_CAN_12_4085
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon